Aflibercept
TED · 593694-2026Contract noticeCloses in 37 days · 2026-10-06
Buyer
Name—
Country—
Published2026-08-28
Deadline2026-10-06
Value
Estimated—
Awarded—
CPV codes
33662100 Medical equipment & pharmaceuticalsDescription
Le marché concerne les fournitures de spécialité pharmaceutique contenant le principe actif « Aflibercept » en solution injectable intravitréenne.
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-08-19 | Infliximab | — | 94% |
| 2026-05-19 | Pomalidomide | — | 93% |
| 2026-08-19 | Rituximab | — | 92% |
| 2026-07-07 | Bévacizumab | — | 91% |
| 2026-06-05 | Aankoop van Aflibercept | Ziekenhuis aan de Stroom vzw (ZAS) BE | 89% |
| 2026-07-22 | Spécialité pharmaceutique à base de Aflibercept | — BE | 89% |